Fairvalue-Calculator Fairvalue-Calculator
EN DE

IGC Pharma, Inc (IGC) Fair Value & Analysis

Healthcare · US · Market cap $27.5M

Price$0.2650
Fair Value$0.2800
Upside+5.7%
Quality95/100
Evidence: Low Range $0.2100 – $0.3600

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

IGC Pharma, Inc (IGC) currently trades at $0.2650, while our model-based Fair Value estimate is $0.2800 — implying the stock looks roughly 5.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is IGC Pharma, Inc (IGC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.2800 versus a price of $0.2650 — about +6% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IGC?
Our 21-model fair value for IGC Pharma, Inc is $0.2800 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.2650.
What is the quality score of IGC?
IGC Pharma, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.